Christopher W. Allard

Author

Also Known As

Christopher W. Allard

Publications

Citations

H-Index

Concepts

All Affiliations

Christopher W. Allard is an author at Bristol-Myers Squibb (United States) specializing in medicinal chemistry, natural sciences, and drug discovery.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	35
2	Natural Sciences	1	1	35
3	Biochemistry	1	1	35
4	Pharmacology	1	1	35
5	Drug Discovery	1	1	35

Christopher W. Allard

Publications

Citations

H-Index

Page 1

	Year	Citations
Discovery of Orally Active Isofuranones as Potent, Selective Inhibitors of Hematopoetic Progenitor Kinase 1 Andrew P. Degnan, Godwin Kumi, Christopher W. Allard, ACS Medicinal Chemistry Letters	2021	51
5,6,7,8-Tetrahydro-1,6-naphthyridine Derivatives as Potent HIV-1-Integrase-Allosteric-Site Inhibitors Kevin M. Peese, Christopher W. Allard, Timothy P. Connolly, Journal of Medicinal Chemistry Lead CompoundsMedicinal ChemistryHiv-1 IntegraseBiochemistryNatural Sciences	2019	35
Design, synthesis and SAR study of novel C2-pyrazolopyrimidine amides and amide isosteres as allosteric integrase inhibitors Manoj Patel, Christopher Cianci, Christopher W. Allard, Bioorganic & Medicinal Chemistry Letters	2020	10

Page 1